Pharmaceutical costs for inflammatory bowel disease units: an issue for department heads? The GESTIONAEII survey

by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Joaquín Hinojosa

Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease

by Federico Argüelles-Arias, Joaquín Hinojosa-del-Val, Isabel Vera-Mendoza

Author's answer: biosimilar therapy for inflammatory bowel disease

by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, Joaquín Hinojosa, Teresa Tejerina
Published 2014-01-01

New contributions to consensus on biosimilars

by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, Joaquín Hinojosa, Teresa Tejerina
Published 2014-03-01

Survey on the use of capsule endoscopy for patients with known or suspected Crohn's disease in Spain

by Ignacio Marín-Jiménez, Ana Gutiérrez, Joaquín Hinojosa, Ingrid Ordás, Jordi Rimola, Asunción Torregrosa
Published 2015-07-01

Joint position statement by "Sociedad Española de Patología Digestiva" (Spanish Society of Gastroenterology) and "Sociedad Española de Farmacología" (Spanish Society of Pharmacolog...

by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, Joaquín Hinojosa, Teresa Tejerina
Published 2013-01-01

How is inflammatory bowel disease managed in Spanish gastroenterology departments?: the results of the GESTIONA-EII survey

by Manuel Barreiro-de-Acosta, Federico Argüelles-Arias, Joaquín Hinojosa, Javier Júdez-Gutiérrez, José María Tenías

M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis.

by Jesús Cosín-Roger, Dolores Ortiz-Masiá, Sara Calatayud, Carlos Hernández, Angeles Alvarez, Joaquin Hinojosa, Juan V Esplugues, Maria D Barrachina
Published 2013-01-01

Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process.

by Dolores Ortiz-Masià, Irene Díez, Sara Calatayud, Carlos Hernández, Jesús Cosín-Roger, Joaquín Hinojosa, Juan V Esplugues, María D Barrachina
Published 2012-01-01

Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of Vitamin D

by Laura Gisbert-Ferrándiz, Jesús Cosín-Roger, Carlos Hernández, Dulce C. Macias-Ceja, Dolores Ortiz-Masiá, Pedro Salvador, Juan V. Esplugues, Joaquín Hinojosa, Francisco Navarro, Sara Calatayud, María D. Barrachina
Published 2020-04-01

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

by María Chaparro, Adrià Aterido, Iván Guerra, Marisa Iborra, Jose Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle García-Sánchez, Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, Isabel Vera, Maria Dolores Martín-Arranz, Borja Hernández-Breijo, Francisco Mesonero, Laura Sempere, Fernando Gomollón, Joaquín Hinojosa, Fernando Bermejo, Belén Beltrán, Ainhoa Rodríguez-Pescador, Jesús María Banales, David Olivares, Patricia Aguilar-Melero, Luis Menchén, Rocío Ferreiro-Iglesias, Isabel Blazquez Gómez, Beatriz Benitez García, Luis G Guijarro, Alicia C Marin, David Bernardo, Sara Marsal, Antonio Julia, Javier P Gisbert
Published 2019-09-01

Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved

by Luis G. Guijarro, David Cano-Martínez, M.Val Toledo-Lobo, Patricia Sanmartín Salinas, María Chaparro, Ana M. Gómez-Lahoz, Sofía Zoullas, Rosa Rodríguez-Torres, Irene D. Román, Laura Sebastián Monasor, Lidia Ruiz-Llorente, María del Carmen Boyano-Adánez, Iván Guerra, Marisa Iborra, José Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle García-Sánchez, Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, Isabel Vera, María Dolores Martín-Arranz, Francisco Mesonero, Laura Sempere, Fernando Gomollón, Joaquín Hinojosa, Melchor Alvarez-Mon, Javier P. Gisbert, Miguel A. Ortega, Borja Hernández-Breijo, on behalf of the PREDICROHN study group from GETECCU
Published 2021-12-01